EMEA-000731-PIP01-09-M03 - paediatric investigation plan
Nonacog beta pegol
PIPHuman
Novo Nordisk A/S
E-mail: paediatrics@novonordisk.com
Tel. +45 4444 8888
P/0139/2019: EMA decision of 17 April 2019 on the acceptance of a modification of an agreed paediatric investigation plan for nonacog beta pegol (Refixia), (EMEA-000731-PIP01-09-M03)